RFP
LRMR icon

Root Financial Partners’s Larimar Therapeutics LRMR Stock Holding History

Root Financial Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.34K Buy
+1,631
New +$6.52K ﹤0.01% 1802

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Root Financial Partners's LRMR Position: Q1 2026 in Review

Root Financial Partners opened a new position in Larimar Therapeutics (LRMR) in Q1 2026: 1,631 shares worth $7.34K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings.

162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Root Financial Partners held 1,631 shares of Larimar Therapeutics worth $7.34K as of Q1 2026.
  • Larimar Therapeutics was a new Root Financial Partners position in Q1 2026.
  • Larimar Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1802 holding.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.